Business Standard

Monday, January 06, 2025 | 08:03 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

UK begins trial of latest virus vaccine this week with 300 candidates

The British government said 300 healthy people will be immunized with two doses of the Covid-19 vaccine candidate developed at Imperial, which has been backed by 41 million pounds

testing, private laboratories, labs, vaccines, doctors, nurses, health, coronavirus
Premium

Oxford University recently began an advanced study involving 10,000 volunteers, and the US is preparing for even larger studies in July that involve 30,000 people.

AP | PTI London
Scientists at Imperial College London will start immunising people in Britain this week with their experimental coronavirus shot, becoming the latest entry into the race to find an effective vaccine to stop the pandemic.

In a statement on Monday, the British government said 300 healthy people will be immunized with two doses of the Covid-19 vaccine candidate developed at Imperial, which has been backed by 41 million pounds ($51 million) in government funding.

So far, the vaccine candidate developed by Imperial College London has only been tested in animals and in the laboratory, where it produced much higher levels of

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in